Alfadocs' SaaS platform is designed to increase the efficiency of medical practices through automated workflows. This should save time and money and ensure satisfied patients. The Munich-based company's platform offers appointment scheduling, diagnostic documentation, X-ray system integration, and service billing.
"We are very proud to have gained two renowned venture capital firms, BayBG and Bayern Kapital, as new investors in what is currently a very challenging market environment for young companies. This confirms our vision of consistently driving forward the digitalization of medical practices across Europe,"
says Alfadocs co-founder and CEO Niklas Fischer-Riepe.
"Our customers are already leveraging the benefits of modern technology to automate their workflows, make the right decisions, and thus provide better healthcare to their patients. With the additional funding, we plan to accelerate our expansion and further build on our technological lead, for example by integrating third-party products into our platform."
Alfadocs: “Convincing market proof”
Peter Graf, Investment Manager at BayBG, says:
"With compelling advantages such as SaaS architecture, cloud solution, and a broad range of features, Alfadocs.com managed to gain a significant share of the medical practice market in its first major market, Italy, within a short period of time. And it did so without extensive marketing or sales activities. This is convincing market proof that demonstrates the medium- and long-term market potential."
